Sarasota, FL -- (SBWire) -- 07/12/2018 --Zion Market Research has published a new report titled "In-Vitro Diagnostics Market by Product (Reagents & Kits and Instruments), by Reagents & Kits (Clinical Chemistry, Immuno-Chemistry, Hematology, Microbiology Culture, Infectious Disease, Genetic Testing, and Others), by Instruments (CC/IA Systems, Micro Array, Sample Processing, Cell Counting, Blood Grouping, and Others), by Software (LIS, Middleware, POC, Support Software, and Others), by Application (Diabetes, Cardiology, Infectious Disease, Cancer, and Others), and by End-User (Laboratories, Hospitals, Point of Care Testing, and Others) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024''. According to the report, global in-vitro diagnostics market was valued at around USD 62.0 billion in 2017 and is expected to reach approximately USD 87.3 billion in 2024, growing at a CAGR of 5.01% between 2018 and 2024.
In-Vitro Diagnostics (IVD) are medical devices and accessories that help in the detection of samples collected from a human body in order to diagnose a particular medical condition, monitor drug therapy, and prevent disease. IVD devices and allied products include reagents, kits, software, calibrators, and control materials. The U.S. Food & Drug Administration (FDA) defined IVD as those 'reagents, instruments and systems intended for diagnosing disease or other conditions'. IVD tests are carried out by specialist physicians, general practitioners, and other certified healthcare professionals. IVD tests can also aid in managing of chronic health conditions like diabetes, cancer, obesity, etc. Besides, the test result can offer insight on effective treatment regime to be provided to the patients. Like all diagnostic tests, IVD helps to enhance care quality, endorse wellness, facilitate early detection of disease, and lessen healthcare cost.
Request For Free Sample Report is Available @ https://bit.ly/2zuzFoO
Global in-vitro diagnostics market growth is bolstered by technological advancements in IVD tests, increasing incidences of chronic & infectious diseases, growing demand for personalized medicine, the emergence of minimally invasive technologies, and rising government expenditure on healthcare. Stringent regulatory policies and unclear reimbursement policies are likely to restrict in-vitro diagnostics market growth for the forecast period.
The global in-vitro diagnostics market is segmented in terms of products, software, application and end users. Product segment is further bifurcated in terms of reagents & kits and instruments. Reagents & Kits comprise clinical chemistry, immunochemistry (immunoassay), hematology, microbiology culture, infectious disease, genetic testing, and others. Immunochemistry (immunoassay) held the largest market share for IVD within reagents & kits segment in 2017. Likewise, instrument segment is further categorized as CC/IA systems, microarray, sample processing, cell counting, blood grouping, and others. Software segment comprises of LIS, middleware, POC support software, and others. POC software is projected to grow with the highest rate in the forecast period. The growth momentum is provided by rising demand for Android & iOS applications for on the go diagnostics. Application segment is classified as cardiology, infectious disease, cancer, diabetes, and others. Likewise, the end-user segment is segregated as laboratories, hospitals, the point of care testing, and others. Hospitals hold the largest market share in terms of revenue owing to rising volume of class II & class III IVD products being used readily for testing.
Inquiry more about this report @ https://bit.ly/2m7fuUr
The Asia Pacific is the fastest growing in-vitro diagnostics market for the forecast period. The market growth is supported by changing healthcare policies, aging population, increasing healthcare expenditure, and growing population. Healthcare expenditure in the Asia Pacific is projected to reach around USD 2,000 billion by 2020 increasing from USD 1,537 billion in 2015. Countries like India, China, Japan, Vietnam, and Indonesia are key markets for IVD products. North America & Europe are amongst the leading revenue generating markets for IVD product. Market growth in both these regions is fostered by increasing R&D expenditure, the significant presence of manufacturers, high-income population, the presence of novel technologies in clinical laboratories, and clarity in regulatory guidelines. Germany, France, and the United Kingdom are amongst the leading markets for IVD products within the European region. Demand for IVD products has spiked in the Central and Eastern Europe within rising influx of immigrants in last five years.
Thermo Fisher Scientific., Roche Diagnostics, Danaher Corporation, Bio-Rad Laboratories, Inc., Becton Dickinson and Company, Agilent Technologies, Biomrieux Sa, Qiagen, Sysmex Corporation, and Ortho-Clinical Diagnostics are some of the leading players involved in the global in-vitro diagnostics market.
Browse Full Report@ https://bit.ly/2NG5JJu
The report segments global In Vitro Diagnostic market as follows:
In-Vitro Diagnostic Market: Products Segment Analysis
Reagents & Kits
Instruments
In-Vitro Diagnostic Market: Reagents & Kits Segment Analysis
Clinical Chemistry
Immuno-Chemistry
Hematology
Microbiology Culture
Infectious Disease
Genetic Testing
Others
In-Vitro Diagnostic Market: Instruments Segment Analysis
CC/IA Systems
MicroArray
Sample Processing
Cell Counting
Blood Grouping
Others
In-Vitro Diagnostic Market: Application Segment Analysis
Diabetes
Cardiology
Infectious Diseases
Cancer
Others
In-Vitro Diagnostic Market: Software Segment Analysis
LIS
Middleware
POC
Support Software
Others
In-Vitro Diagnostic Market: End-User Industry Segment Analysis
Laboratories
Hospitals
Point of Care Testing
Others
In-Vitro Diagnostic Market: Regional Segment Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa
About Zion Market Research
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
In-Vitro Diagnostics Market Reflecting a CAGR of 5.01% by 2024
Global In-Vitro Diagnostics Market Is Set For A Rapid Growth And Is Expected To Reach Around USD 87.3 Billion by 2024